NOV 21, 2017 7:02 AM PST

"Beneficial Cell Suicide" Fights Pathogens in the Bloodstream

WRITTEN BY: Kara Marker

A new discovery of how specialized immune cells carry out their last resort effort to kill pathogens could help scientists improve and regulate a variety of immune responses. In the present study, published in the journal Developmental Cell, scientists watch how immune cells respond to a fungal infection in the context of mice models.

This photograph shows bacteria (Shigella flexneri) trapped in a NET. The mesh-like structure of the NET is visible between two still-intact neutrophils. Credit: Volker Brinkmann

Neutrophils are cells of the innate immune system, which means that they respond first, they respond quickly, and they respond to everything. Usually the first cells to arrive at the site of infection, neutrophils respond to chemical messengers released by both the invading pathogens and the infected and dying cells. In the present study, researchers analyze neutrophil extracellular traps (NETs), where neutrophils release bundles of processed chromatin as a tactic for containing pathogenic invasions.

First author Borko Amulic, PhD, calls this response “beneficial cell suicide.”

"When neutrophils get overwhelmed, when they can no longer deal with a microbial threat by just engulfing it, that's when the NETs are released,” Amulic explained.

Aside from releasing NETs, neutrophils participate in the immune response by releasing their own chemical messengers to recruit more cells to the site and by phagocytosis, the process of engulfing and digesting pathogens.

The new study aimed to examine how NETs are released and how they stop a fungal infection. Researchers found that after NETs are released, the neutrophil “anchors itself in the tissue and breaks down its nuclear envelope.” Interestingly, cells usually only do so in the moments right before they divide, which lead researchers to believe that neutrophils might be using the same cell cycle proteins involved in cell division to release NETs.

Researchers tested their theory in a mice model where neutrophils were incapable of producing cell cycle proteins. Subsequently, these neutrophils were also barred from releasing NETs and were quickly overcome by fungal infections.

The relationship between NET release and cell cycle proteins was confirmed in humans when researchers observed brains under attack by fungal infections, seeing neutrophils using cell cycle proteins.

"The ultimate goal for this research is to interfere clinically, either when too few or too many NETs are being produced," says Amulic. "Also, this is just a really fascinating cell biological phenomenon."

Sources: Nature Reviews, The Journal of Cell Biology, Cell Press

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JAN 28, 2021
Neuroscience
Immune Cells Destroy Synapses in Multiple Sclerosis
JAN 28, 2021
Immune Cells Destroy Synapses in Multiple Sclerosis
Researchers from Germany have found that Multiple sclerosis (MS)-associated inflammation in the cerebral cortex destroys ...
FEB 10, 2021
Drug Discovery & Development
Black Men Respond Best to Immunotherapy for Prostate Cancer
FEB 10, 2021
Black Men Respond Best to Immunotherapy for Prostate Cancer
Researchers from Northwestern University have found that Black men and men of African ancestry respond better than men f ...
FEB 25, 2021
Immunology
Asthma Inhalers Slash Risk of COVID Hospitalization by 90 Percent
FEB 25, 2021
Asthma Inhalers Slash Risk of COVID Hospitalization by 90 Percent
For mild cases of COVID, doctors recommend the usual regimen for getting through a cold or flu: Staying hydrated and res ...
MAR 09, 2021
Immunology
A 'Plug-and-Play' CRISPR Therapy for Flu and COVID
MAR 09, 2021
A 'Plug-and-Play' CRISPR Therapy for Flu and COVID
Researchers have developed a CRISPR treatment that could potentially treat both viruses that cause COVID-19 and influenz ...
APR 05, 2021
Cancer
Introducing DeepTCR, the deep-learning software for T-cell receptor sequencing data
APR 05, 2021
Introducing DeepTCR, the deep-learning software for T-cell receptor sequencing data
A team from the Bloomberg~Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center is introdu ...
MAY 12, 2021
Health & Medicine
Researchers Discover a New Genetic Disease that Prevents Antibody Formation
MAY 12, 2021
Researchers Discover a New Genetic Disease that Prevents Antibody Formation
Doctors at the Children's Hospital of Philadelphia discovered a new genetic disease that prevents B cell development.
Loading Comments...